Sign up to our newsletter Subscribe
Understanding societal preferences for priority by disease severity in England & Wales
OHE Expert Profile
Phill O’Neill
Information Specialist
Phill has over 25 years’ experience in the use of pharmaceutical industry data and information. His research interests include the economics of the pharmaceutical market, the productivity, and outputs of NICE, and benchmarking industry performance. Phill was the lead analyst for several industry and Government economic benchmarking initiatives including the Pharmaceutical Industry Competitiveness Taskforce (PICTF) Indicators, Scottish Market Understanding Initiative, and G10 Competitiveness Indicators for the EU. Phill is a previous chair of the EFPIA Statistics Group.
Latest Publications
Dementia in the UK: Estimating the Potential Future Impact and Return on Research Investment
NICE enough? Do NICE’s Decision Outcomes Impact International HTA Decision-making?
NICE ‘Optimised’ Decisions: What is the Recommended Level of Patient Access?
Measurement of Medicines Expenditure in the Context of the 2014-18 PPRS
